• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低剂量 CT 扫描肺癌筛查中使用正电子发射断层扫描和体积倍增时间的联合应用。

Combined use of positron emission tomography and volume doubling time in lung cancer screening with low-dose CT scanning.

机构信息

Department of Radiology, Gentofte University Hospital, Niels Andersens vej 65, 2900 Hellerup, Denmark.

出版信息

Thorax. 2011 Apr;66(4):315-9. doi: 10.1136/thx.2010.136747. Epub 2010 Dec 17.

DOI:10.1136/thx.2010.136747
PMID:21169285
Abstract

BACKGROUND

In lung cancer screening the ability to distinguish malignant from benign nodules is a key issue. This study evaluates the ability of positron emission tomography (PET) and volume doubling time (VDT) to discriminate between benign and malignant nodules.

METHODS

From the Danish Lung Cancer Screening Trial, participants with indeterminate nodules who were referred for a 3-month rescan were investigated. Resected nodules and indolent nodules (ie, stable for at least 2 years) were included. Between the initial scan and the 3-month rescan, participants were referred for PET. Uptake on PET was categorised as most likely benign to malignant (grades I-IV). VDT was calculated from volume measurements on repeated CT scans using semiautomated pulmonary nodule evaluation software. Receiver operating characteristic (ROC) analyses were used to determine the sensitivity and specificity of PET and VDT.

RESULTS

A total of 54 nodules were included. The prevalence of lung cancer was 37%. In the multivariate model both PET (OR 2.63, p<0.01) and VDT (OR 2.69, p<0.01) were associated with lung cancer. The sensitivities and specificities of both PET and VDT were 71% and 91%, respectively. Cut-off points for malignancy were PET>II and VDT<1 year, respectively. Combining PET and VDT resulted in a sensitivity of 90% and a specificity of 82%; ROC cut-off point was either PET or VDT indicating malignancy.

CONCLUSION

PET and VDT predict lung cancer independently of each other. The use of both PET and VDT in combination is recommended when screening for lung cancer with low-dose CT.

摘要

背景

在肺癌筛查中,能够区分良恶性结节是一个关键问题。本研究评估正电子发射断层扫描(PET)和体积倍增时间(VDT)区分良恶性结节的能力。

方法

从丹麦肺癌筛查试验中,选择了因不确定结节而被转诊进行 3 个月复查的参与者进行研究。包括切除结节和惰性结节(即至少稳定 2 年)。在初次扫描和 3 个月复查之间,参与者被转诊进行 PET 检查。PET 摄取分为最可能良性到恶性(等级 I-IV)。VDT 是使用半自动化肺部结节评估软件从重复 CT 扫描的体积测量中计算出来的。使用接收者操作特征(ROC)分析来确定 PET 和 VDT 的敏感性和特异性。

结果

共纳入 54 个结节。肺癌的患病率为 37%。在多变量模型中,PET(OR 2.63,p<0.01)和 VDT(OR 2.69,p<0.01)均与肺癌相关。PET 和 VDT 的敏感性和特异性分别为 71%和 91%。恶性肿瘤的截断值分别为 PET>II 和 VDT<1 年。PET 和 VDT 的联合使用可提高敏感性至 90%,特异性为 82%;ROC 截断值为 PET 或 VDT 表示恶性肿瘤。

结论

PET 和 VDT 可独立预测肺癌。在使用低剂量 CT 进行肺癌筛查时,建议同时使用 PET 和 VDT。

相似文献

1
Combined use of positron emission tomography and volume doubling time in lung cancer screening with low-dose CT scanning.低剂量 CT 扫描肺癌筛查中使用正电子发射断层扫描和体积倍增时间的联合应用。
Thorax. 2011 Apr;66(4):315-9. doi: 10.1136/thx.2010.136747. Epub 2010 Dec 17.
2
Optimisation of volume-doubling time cutoff for fast-growing lung nodules in CT lung cancer screening reduces false-positive referrals.优化 CT 肺癌筛查中体积倍增时间截断值以减少快速生长肺结节的假阳性转诊。
Eur Radiol. 2013 Jul;23(7):1836-45. doi: 10.1007/s00330-013-2799-9. Epub 2013 Mar 19.
3
Comparison of three software systems for semi-automatic volumetry of pulmonary nodules on baseline and follow-up CT examinations.三种软件系统在基线和随访CT检查中对肺结节进行半自动容积测量的比较。
Acta Radiol. 2014 Jul;55(6):691-8. doi: 10.1177/0284185113508177. Epub 2013 Oct 16.
4
Differentiation of malignant and benign pulmonary nodules with quantitative first-pass 320-detector row perfusion CT versus FDG PET/CT.使用 320 层螺旋 CT 定量首过灌注成像与 FDG PET/CT 鉴别肺良恶性结节。
Radiology. 2011 Feb;258(2):599-609. doi: 10.1148/radiol.10100245.
5
Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules.低剂量计算机断层扫描肺癌筛查:一种针对基线肺结节的非侵入性诊断方案
Lung Cancer. 2008 Sep;61(3):340-9. doi: 10.1016/j.lungcan.2008.01.001. Epub 2008 Mar 4.
6
Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.CT 检测到肺结节患者的肺癌概率:来自低剂量 CT 筛查 NELSON 试验数据的预设分析。
Lancet Oncol. 2014 Nov;15(12):1332-41. doi: 10.1016/S1470-2045(14)70389-4. Epub 2014 Oct 1.
7
Positron emission tomography in the diagnostic work-up of screening-detected lung nodules.正电子发射断层扫描在筛查发现的肺结节诊断中的应用。
Eur Respir J. 2015 Feb;45(2):501-10. doi: 10.1183/09031936.00066514. Epub 2014 Sep 26.
8
Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study.用低剂量计算机断层扫描筛查肺癌的过度诊断估计:一项队列研究。
Ann Intern Med. 2012 Dec 4;157(11):776-84. doi: 10.7326/0003-4819-157-11-201212040-00005.
9
[The volume and mass growth of persisted pulmonary nodules detected in low-dose CT screening and its influence factors].[低剂量CT筛查中持续性肺结节的体积和质量增长及其影响因素]
Zhonghua Zhong Liu Za Zhi. 2018 Apr 23;40(4):274-279. doi: 10.3760/cma.j.issn.0253-3766.2018.04.007.
10
Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.低剂量 CT 肺癌筛查中新出现实性结节的发生率和肺癌概率:来自随机、对照 NELSON 试验的数据分析。
Lancet Oncol. 2016 Jul;17(7):907-916. doi: 10.1016/S1470-2045(16)30069-9. Epub 2016 Jun 6.

引用本文的文献

1
Neural network-based model for evaluating inert nodules and volume doubling time in T1 lung adenocarcinoma: a nested case-control study.基于神经网络的T1期肺腺癌惰性结节及体积倍增时间评估模型:一项巢式病例对照研究
Front Oncol. 2023 May 24;13:1037052. doi: 10.3389/fonc.2023.1037052. eCollection 2023.
2
A Rare Case Diagnosed by Videothoracoscopic Lung Biopsy: Diffuse Pulmonary Meningotheliomatosis.经电视胸腔镜肺活检确诊的罕见病例:弥漫性肺脑膜皮瘤病
Case Rep Pulmonol. 2021 Aug 28;2021:1990433. doi: 10.1155/2021/1990433. eCollection 2021.
3
Lung cancer screening: who pays? Who receives? The European perspectives.
肺癌筛查:谁来付费?谁能受益?欧洲的观点。
Transl Lung Cancer Res. 2021 May;10(5):2395-2406. doi: 10.21037/tlcr-20-677.
4
Epithelioid hemangioendothelioma: evaluation by F-FDG PET/CT.上皮样血管内皮瘤:F-FDG PET/CT评估
Am J Nucl Med Mol Imaging. 2021 Apr 15;11(2):77-86. eCollection 2021.
5
Primary lung neoplasms presenting as multiple synchronous lung nodules.以多个同步性肺结节为表现的原发性肺部肿瘤。
Eur Respir Rev. 2020 Sep 2;29(157). doi: 10.1183/16000617.0142-2019. Print 2020 Sep 30.
6
The growth feature and its diagnostic value for benign and malignant pulmonary nodules met in routine clinical practice.常规临床实践中遇到的肺结节的生长特征及其对良恶性的诊断价值。
J Thorac Dis. 2020 May;12(5):2019-2030. doi: 10.21037/jtd-19-3591.
7
Utility of FDG PET/CT for assessment of lung nodules identified during low dose computed tomography screening.FDG PET/CT 用于评估低剂量 CT 筛查中发现的肺部结节的应用价值。
BMC Med Imaging. 2020 Jun 22;20(1):69. doi: 10.1186/s12880-020-00469-0.
8
EU Policy on Lung Cancer CT Screening 2017.2017年欧盟肺癌CT筛查政策
Biomed Hub. 2017 Nov 21;2(Suppl 1):154-161. doi: 10.1159/000479810. eCollection 2017 Nov-Dec.
9
Transthoracic ultrasound-guided biopsy in the hands of chest physicians - a stepwise approach.胸科医生操作的经胸超声引导下活检——一种循序渐进的方法。
Eur Clin Respir J. 2019 Feb 14;6(1):1579632. doi: 10.1080/20018525.2019.1579632. eCollection 2019.
10
Improved discrimination between benign and malignant LDCT screening-detected lung nodules with dynamic over static F-FDG PET as a function of injected dose.提高动态 F-FDG PET 与静态 F-FDG PET 比较在良恶性 LDCT 筛查检出肺结节中的诊断效能与注射剂量的关系。
Phys Med Biol. 2018 Sep 6;63(17):175015. doi: 10.1088/1361-6560/aad97f.